References
- Zhang X , RakeshKP, ShantharamCSet al. Podophyllotoxin derivatives as an excellent anticancer aspirant for future chemotherapy: a key current imminent needs. Bioorg. Med. Chem.26(2), 340–355 (2018).
- Zhao Y , WangCN, WuZH, FangJH, ZhuL. Synthesis and antitumor activity of novel aroylthiourea derivatives of podophyllotoxin. Invest. New Drugs30(1), 17–24 (2012).
- Shankaraiah N , KumarNP, AmulaSBet al. One-pot synthesis of podophyllotoxin–thiourea congeners by employing NH2SO3H/NaI: anticancer activity, DNA topoisomerase-II inhibition, and apoptosis inducing agents. Bioorg. Med. Chem. Lett.25(19), 4239–4244 (2015).
- Hande KR . Etoposide: four decades of development of a topoisomerase II inhibitor. Eur. J. Cancer34(10), 1514–1521 (1998).
- Jin Y , ChenSW, TianX. Synthesis and biological evaluation of new spin-labeled derivatives of podophyllotoxin. Bioorg. Med. Chem.14(9), 3062–3068 (2006).
- Bhat BA , ReddyPB, AgrawalSK, SaxenaAK, KumarMS, QaziGN. Studies on novel 4β-[(4-substituted)-1,2,3-triazol-1-yl] podophyllotoxins as potential anticancer agents. Eur. J. Med. Chem.43(10), 2067–2072 (2008).
- Castro MA , CorralJM, GordalizaMet al. Synthesis and biological evaluation of new selective cytotoxic cyclolignans derived from podophyllotoxin. J. Med. Chem.47(5), 1214–1222 (2004).
- Wu GR , XuB, YangYQet al. Synthesis and biological evaluation of podophyllotoxin derivatives as selective antitumor agents. Eur. J. Med. Chem.155(15), 183–196 (2018).
- Reddy VG , BonamSR, ReddyTSet al. 4β-amidotriazole linked podophyllotoxin congeners: DNA topoisomerase-IIα inhibition and potential anticancer agents for prostate cancer. Eur. J. Med. Chem.144(20), 595–611 (2018).
- Sun WX , JiYJ, WanYet al. Design and synthesis of piperazine acetate podophyllotoxin ester derivatives targeting tubulin depolymerization as new anticancer agents. Bioorg. Med. Chem. Lett.27(17), 4066–4074 (2017).
- Zi CT , YangD, DongFWet al. Synthesis and antitumor activity of novel per-butyrylated glycosides of podophyllotoxin and its derivatives. Bioorg. Med. Chem.23(7), 1437–1446 (2015).
- Liu H , LiaoJX, HuY, TuYH, SunJS. A highly efficient approach to construct (epi)-podophyllotoxin-4-O-glycosidic linkages as well as its application in concise syntheses of etoposide and teniposide. Org. Lett.18(6), 1294–1297 (2016).
- Song WZ , ZhaoY, LynchJC, KimHJ, TangWP. Divergent de novo synthesis of all eight stereoisomers of 2,3,6-trideoxyhexopyranosides and their oligomers. Chem. Comm.51(98), 17475–17478 (2015).
- Wang HYL , WuBL, ZhangQ, KangSW, RojanasakulY, O'DohertyGA. C5′-alkyl substitution effects on digitoxigenin α-l-glycoside cancer cytotoxicity. ACS Med. Chem. Lett.2(4), 259–263 (2011).
- Li MZ , LiY, MrozowskiRMet al. Synthesis and structure–activity relationship study of 5a-carbasugar analogues of SL0101. ACS Med. Chem. Lett.6(1), 95–99 (2015).
- Zhao W , ZhouC, GuanZY, YinP, ChenFS, TangYJ. Structural insights into the inhibition of tubulin by the antitumor agent 4β-(1,2,4-triazol-3-ylthio)-4- deoxypodophyllotoxin. ACS Chem. Biol.12(3), 746–752 (2017).
- Wang XY , LingY, WangHet al. Novel pleuromutilin derivatives as antibacterial agents: synthesis, biological evaluation and molecular docking studies. Bioorg. Med. Chem. Lett.22(19), 6166–6172 (2012).
- Ling Y , WangXY, WangHet al. Design, synthesis, and antibacterial activity of novel pleuromutilin derivatives bearing an amino thiazolyl ring. Arch. Pharm. Chem. Life Sci.345(8), 638–646 (2012).
- Mrozowski RM , VemulaR, WuBet al. Improving the affinity of SL0101 for RSK using structure-based design. ACS Med. Chem. Lett.4(2), 175–179 (2013).
- Shareef MA , DuschariaD, RamasatyaveniGet al. Investigation of podophyllotoxin esters as potential anticancer agents: synthesis, biological studies and tubulin inhibition properties. Eur. J. Med. Chem.89(7), 128–137 (2015).
- Luduena RF , RoachMC. Interaction of tubulin with drugs and alkylating agents. 2. Effects of colchicine, podophyllotoxin, and vinblastine on the alkylation of tubulin. Biochem.20(15), 4444–4450 (1981).